Dow Down 1.50% Nasdaq Down 2.41%

PTC Therapeutics, Inc. (PTCT)

-NasdaqGS
6.26 Down 0.40(6.01%) 4:00PM EDT
|After Hours : 6.26 0.00 (0.00%) 5:24PM EDT
Prev Close:6.66
Open:6.61
Bid:6.26 x 200
Ask:7.00 x 500
1y Target Est:17.67
Beta:0.804036
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:6.25 - 6.74
52wk Range:5.27 - 62.15
Volume:1,870,810
Avg Vol (3m):1,720,570
Market Cap:214.50M
P/E (ttm):N/A
EPS (ttm):-5.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PTCTDown 6.01%214.50M
VRTXDown 2.52%19.75B
SRPTDown 8.48%812.35M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-4.93
Quarterly EPS Est (Jun-16) :-1.28
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback